Matinas BioPharma Holdings, Inc.
Symbol: MTNB (NYSE)
2.42
▲ (46.91%) 0.774
Company Description:
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
Key Stats
- Today's Open: $1.59
- Today's High: $3.07
- Today's Low: $1.565
- Today's Volume: 22.62M
- Yesterday Close: $1.65
- Yesterday High: $1.67
- Yesterday Low: $1.35
- Yesterday Volume: 111.79K
- Last Min Volume: 0
- Last Min High: $2.424
- Last Min Low: $2.424
- Last Min VWAP: $0
Company Profile
- Name: Matinas BioPharma Holdings, Inc.
- Website: https://www.matinasbiopharma.com
- Listed Date: 2014-07-21
- Location: BEDMINSTER, NJ
- Market Status: Active
- CIK Number: 0001582554
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $8.39M
- Round Lot: 100
- Outstanding Shares: 5.09M
- Asset Type: CS
RECENT FILINGS FOR MTNB
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-06 | 8-K | View |
| 2025-06-23 | S-8 | View |
| 2025-06-23 | 8-K | View |
| 2025-05-15 | 10-Q | View |
| 2025-05-12 | DEF 14A | View |
| 2025-05-02 | PRE 14A | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 4 | View |
| 2025-05-02 | 8-K | View |
| 2025-04-29 | EFFECT | View |
| 2025-04-29 | ARS | View |
| 2025-04-29 | 424B3 | View |
| 2025-04-28 | CORRESP | View |
| 2025-04-28 | UPLOAD | View |
| 2025-04-22 | S-3 | View |
Latest News on MTNB